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In order to provide blood-compatible interfaces for artificial vascular pros- 
theses, technology has proceeded along several lines, including the use of (1) 
synthetic materials such as neutral, ionic and polarized polymers and pyrolytic 
carbons; ( 2 )  additive containing materials such as heparin; ( 3 )  hydrogels; (4) 
woven and nonwoven fiber scaffolds lined with cells or fibrin; and ( 5 )  com- 
posites of the above.', Although fiber scaffolds (in the form of porous woven 
or knitted fabrics) have been in use for many years, healing is somewhat capri- 
cious and is always preceded by the formation of a fibrin coagulum that subse- 
quently undergoes organization and may or may not give rise to a healed endo- 
thelium. The use of porous prostheses permits flexion of the vessel as well as 
adherence of the fibrin coagulum and the potential for transinterstices growth 
of tissue, which, it is hoped, will lead to a healed pseudointima. Since adherence 
of the pseudointima (whether cellular or fibrin) and healing depends to a great 
extent on the surface characteristics and porosity of the p r o s t h e s i ~ , ~ - ~ ~  many 
types of surfaces have been developed (woven, knitted, velours, flocks, lattices, 
etc.) to promote better healing. Emphasis recently has been on the production 
of prostheses with smaller fibers and pores such as "Weavnit," 0 "Microknit," lo 
and "Warpknit" for clinical application. On the experimental side, in recent 
years nonwoven microfiber scaffolds have been produced as an alternative 
to woven and knitted prostheses. 
Heart-assist devices must of necessity be nonporous, given the nature of the 
pneumatic pumps. Since blood pumps have large surfaces exposed to the blood, 
the potential for thrombus, degradation of blood proteins, and hemolysis is 
great. To circumvent these problems, fabric-lined pumps have been devel- 
oped.15-?'I However, such nonporous prostheses or pumps permit no growth of 
cells except from the natural vessel at the anastomotic line. Since this neointima 
comes only from the intima or media of the vessels at the suture line in both 
heart assists or in arterial grafts,'l production of cellular pseudointimas before 
implantation of the devices would be beneficial. 
Various methods of pseudointima production have been attempted, includ- 
ing: (1)  the use of tissue fragments,16* *O ( 2 )  trypsinization of organs, vis- 
cera, and so on, followed by immediate seeding of prostheses with dispersed 
cells,'o (3) derivation of cells from tissues followed by cultivation in vitro and 
seeding of subcultured 22-35 Numerous cell sources for culture-derived 
pseudointimas have been tried, including skin,li, ** arteries," 
veins,19, 20,  2 2  subcutaneous tissue,l9, 20 lung,16- 2 n  pleura,'? fascia,'? granulation 
tissue,lg~ 2'1 28 bone marrow,lQ macrophages,'3 pericardiurn,'O. 22 fibro- 
* Supported by contract no. NIH-N01-HB-2054 from the National Heart and 
Lung Institute, National Institutes of Health, Bethesda, Md. 20014. 
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blasts,?% 21, 28 huffy COat,25 endothelial cells,lfi, 22.  26, 26,  30, 32 ,  33. 35 smooth mus- 
~ l e , ~ ~  skeletal muscle,16$ ascitic cells,lQ epidermis,?6. 2% 31-33 WI-38 
 cell^,^^-*^^ 31-33 and urothelium) . z g  
This paper reports some of our experiences on the development of pseudo- 
intimas on nonwoven microfiber scaffolds with cells derived from human tissue, 
namely, WI-38, epidermal, endothelial, and urothelial cells. 
MATERIALS AND METHODS 
Cell Sources 
Diploid WI-38 cells derived from embryonic human lung were obtained 
from Professor L. Hayflick of Stanford University at approximately the twelfth 
passage. These cells were used to screen microfabrics for biocompatibility and 
to develop techniques for producing pseudointimas. Human epidermal cells 
were obtained from split-thickness skin explants obtained from the University 
of Michigan Dermatology Clinic. Endothelium was surgically derived from 
stripped veins, aneurysmectomy, and normal veins of kidney-transplant ca- 
davers. Urinary tract epithelium, which we have referred to as urothelium, was 
obtained from biopsies of urethra, bladder, and renal pelves. 
Epidermal, endothelial, and urothelial cells were isolated by treatment of 
the corresponding explants with 0.25% trypsin and 1% EDTA in balanced 
salt solution (Earle's calcium and magnesium-free, lX, Grand Island Biological 
Company). After incubation of the explants for 15-20 minutes at 37" C in 
the above solution, the epithelial layer was gently teased off from the underlying 
connective tissue and transferred to growth medium in Falcon plastic tissue 
culture flasks. Growth medium consisted of Eagle's Basal Medium (BME, 
cat no. G13, Grand Island Biological Company) buffered with 0.10 M HEPES 36 
(N-2 hydroxyethyl piperazine sulfonic acid, California Biochemical Corp.) , 
FIGURE 1. Tube and disc of the type used for compatibility testing and pseudo- 
intimal development. x 1.5. 
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FIGURE 2. Polyester (polytetramethylene terephthalate) microfiber scaffold pro- 
duced by hot-melt extrusion. a=Microfabric surface ( x 380); bxcross section of 
tube showing embeddment (E) of microfibers (M)  into nonporous estane wall (W) 
( X  130). 
buffered to pH 7.4 at room temperature. The medium was supplemented with 
10% bovine serum and 50 pg/ ml Aureomycin Chlortetracycline HCl (Lederle 
Division, American Cyanimide Corp.) 
Micro fabrics 
Polyurethane (5714-F1 estane) tubes ( 1 8  X 50 mm) and discs (15 mm in 
diameter) lined with microfiber scaffolds of nylon 6,6, carbon-coated nylon, 
polyester (polytetramethylene terephthalate) , and polypropylene were used in 
these studies (FIGURE 1) .  Nylon 6,6 and polyester microfibers were produced 
by hot melt extrusion to give a nonwoven microfiber mesh of 0.2-2 pm fibers 
bonded to the nonporous estane by a negative casting procedure by Abcor 
Corporation, Cambridge, Mass. (FIGURE 2) .  Some of the nylon was coated 
with a 3000 A layer of pyrolytic carbqn w by Gulf Atomic Corporation, San 
Diego, Calif. or Parylene-C,ll, and microwave discharge-treated. Polypropy- 
lene (Union Carbide, Inc., Boundbrook, N.J.) microfibers were produced by 
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coextrusion of polypropylene and acrylic copolymers followed by extraction of 
the acrylic component and stretching or horizontal drafting of the extruded 
40 The resulting fibers were 0.2-2 pm in diameter and were supplied in 
two configurations, a nonvertically drafted fiber mat produced by horizontal 
drafting only, and a vertically drafted fiber mat produced by horizontal and 
vertical drafting (FIGURE 3). These were attached to estane tubes and discs 41 
and were coated with a 5000 A layer of Parylene-C. All tubes and discs were 
sterilized by beta radiation. 
Preparation of Pseudointimas 
Pseudointimas were produced by a four-step process 2 7 ,  2 9 v  3 2  which included 
(1) washing and degassing of fabric, (2) seeding of cells, ( 3 )  stabilization, and 
(4) static or perfusion culture. Prior to seeding with cells, the tubes or discs 
were washed and degassed in media at  low negative pressures (10-15 mm Hg). 
The cell sources, propagated as monolayer cultures, were trypsinized (0.25% 
in balanced salt solution), washed in balanced salt solution, and seeded with 
an appropriate number of cells to give approximately 2000-1 0,000 cells/mm2 
of fabric surface. Seeding of tubes and discs was accomplished by centrifugation 
of cells into the fabric at about 50 X g for approximately one minute. Emigra- 
tion of the cells from the fabric was prevented by “stabilization” of the tube or 
disc in a confined environment for about 12 hours. After stabilization, the tubes 
were placed in a modified New Brunswick Rollacell perfusion apparatus and 
cultivated for six days. Tubes were rotated at 11 revolutions per hour and 
perfused for 5-10 seconds every hour, depending on the glucose content of the 
effluent medium. Discs were cultivated under static conditions in T-75 Falcon 
tissue-culture flasks for a corresponding amount of time, with media changes 
every two days. 
Evaluation 
Tubes and discs were evaluated by light microscopy and scanning and trans- 
mission electron microscopy. Samples were fixed in 2.5 % glutaraldehyde and 
0.1 M cacodylate buffer at pH 7.4 followed by postosmication and dehydration 
in a graded series of alcohols. Samples for light microscopy and transmission 
electron microscopy were embedded in Epon, cut at 1 pm and stained with 
methylene blue. Selected samples were thin-sectioned and stained with uranyl 
acetate and lead citrate for transmission electron microscopy. Corresponding 
samples were prepared for scanning electron microscopy by freeze- or critical- 
point drying followed by gold or gold-paladium coating. Pseudointimas were 
evaluated by estimating the percentage of surface area of the tube or disc 
covered with cells when observed with the scanning electron microscope. Pene- 
tration of fabric by cells and cell-fabric relationships were studied by light and 
transmission electron microscopy. 
RESULTS 
Pseudointima Appearance 
Throughout our experiments we have emphasized the use of human cells, 
since the ultimate usefulness of pseudointimal lined tubes lies in man. The 
WI-38 cell line, derived from fetal human lung, has been widely used for 
biological testing and in studies of population dynamics and aging.4?-45 We have 
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FIGURE 3.  Parylene-C coated polypropylene microfiber scaffold. a =Surface 
( x 1400); b=cross section of nonvertically drafted mat showing thickness of micro- 
fiber mat ( M )  and attachment to the impermeable estane backing (W) by adhesive 
(A)  ( x 140); c=cross section of a vertically drafted microfiber scaffold ( x 140). 
Note the thinner fiber mat (M)  and relative looseness of fibers in comparison to the 
nonvertically drafted mat. 
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FIGURE 4. Pseudointima produced by WI-38 cells on polyester microfiber scaffold 
( x 2600). 
found this cell line very useful for testing biocompatibility of materials and for 
developing techniques.22-x7 Technically, WI-38 cells produced excellent, com- 
plete pseudointimas when seeded into microfiber scaffolds (FIGURE 4). How- 
ever, the immune reaction of the recipient against such a cell line mitigates 
against its use in clinical situations. We therefore experimented with three rela- 
tively easily obtained, potentially autologous human cells for the production of 
pseudointimas, namely, epidermis, endothelium, and urothelium. 
Because of the ease of acquisition and their abundance, epidermal cells 
represent perhaps the most potentially useful cells for lining prostheses. Like 
WI-38 cells, human epidermally derived cells produce excellent pseudointimas 
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in vitro (FIGURE 5 ) .  They are smooth, confluent, and usually consist of one to 
four layers of cells (FIGURE 6) ,  after seven days in culture. 
Theoretically, endothelium would appear to be the most desirable for lining 
prostheses because of its inherent blood compatibility. These cells produce 
excellent pseudointimas (FIGURE 7) .  The difficulties in rapidly propagating 
suficient cells from adult human endothelium, however, limits their potential 
usefulness at this time. 
Although urothelium (particularly from bladder) is available in limited 
quantities, it can be obtained in amounts adequate to seed small vessels if culti- 
vation time is sufficient. The limited number of experiments that have been 
done with this cell source seems to indicate that these cells will also produce 
confluent cell layers on prostheses if enough cells are seeded (FIGURE 8) .  
Microfiber Compatibility 
Compatibility of microfiber scaffolds was evaluated by seeding various 
fabrics with the WI-38 cells and assessing the percentage of the surface area 
covered with cells after seven days in vitro. As can be seen from TABLE 1. 
nylon 6,6 fabric (Abcor) gave better pseudointimas (69% coverage) without 
FIGURE 5 .  Surface of a pseudointima produced by human epidermal cells on poly- 
ester microfabric ( x  180). 
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FIGURE 6 .  a+b=Cross section of a pseudointima (P)  produced by human epi- 
dermal cells on nonvertically drafted polypropylene microfibers ( M )  ( x 150;SOO) ; 
c=electron micrograph of a portion of a similar pseudointima. Note that cells at the 
luminal surface (L) are flattened, whereas the deeper cells near the microfiber (MF) 
are polygonal ( x 3500). 
a negative surface charge imparted by microwave discharge treatment. Carbon 
or Parylene-C coating of nylon (FIGURE 9) gave a dramatic improvement in 
coverage ( 100% and 93 % , respectively). Parylene-C coated polypropylene 
fibers, whether vertically (71 % coverage) or nonvertically drafted (7 1 % cover- 
age) gave slightly poorer results, but still produced good pseudointimas. The 
Burke1 & Kahn: Microfiber Scaffolds 427 
polytetramethylene terephthaIate fabric with no special treatment or  coating 
gave 77% coverage. It was apparent from these early experiments that carbon- 
coated nylon was the best pseudointimal substrate. However, transmission 
electron microscopy showed the carbon coating to be brittle (FIGURE 10) and 
subject to phagocytosis. Coupled with the known, limited life span of nylon 
in vivo, these findings led to the exclusion of all of the nylon fabrics for studies 
with potentially autologous cell lines. 
Fabric coverages with epidermal, endothelial, and urothelial cells are shown 
in TABLE 2. Epidermal cells grew well on all of the fabrics tested, whereas 
endothelial and urothelial cells did considerably worse on the Parylene-C coated 
polypropylene. From the results of these and of the WI-38 experiments it is 
FIGURE 7. Surface view of a pseudointima produced by human endothelial cells on 
a polyester microfiber scaffold ( x 1400). 
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apparent that the polytetramethylene terephthalate microfibers offered the best 
substrates for pseudointimal development with the cell lines which we have 
tested. These microfiber scaffolds have the additional advantage of being firmly 
embedded (FIGURE 2b) in the estane backing and therefore are resistant to 
shearing forces. 
FIGURE 8. Pseudointima produced by urothelium on polyester microfibers. The cell 
layer is incomplete in this specimen because not enough cells/mm2 were seeded 
( x 1100). 
Also important in the development of pseudointimas in vitro was the culture 
system used (TABLE 3 ) .  Devices cultivated in roller bottles by perfusion require 
significantly fewer cells/mm2 (p <.05)  to give 80-100% coverage within seven 
days when compared to static cultures under the same conditions. Similarly, 
perfusion culture requires the least number of cells/mm2 to give the same 
coverage. 
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TABLE 1
MICROFIBER COMPATIBILITY WITH WI-38 CELLS 
Coating or Number of Mean % of Surface 
Fiber Type Treatment Experiments * Area Covered 
Nylon 6,6 t - (30) 69 30.9 n 
Nylon-6,6 t Microwave (18) 54 47.7 q 
Nylon-6,6 t Parylene-C 5 (13) 93 8.5 n 
Nylon-6, 6 t Pyrolytic Carbon ( 6 )  100 0.0 n 
Polytetramethylene 
Polypropylene- Parylene-C $ 
Polypropylene Vert. Parylene-C $ 
Terephthalate t - (48 1 77 28.9 '1[ 
Non-Vert. Draft 5 Microwave (90) 71 34.6 
Draft t Microwave (75)  71 37.8ll 
* ( )=Number of cases. 
t Abcor, Inc. 
t Union Carbide, Corp. 
§ Gulf Atomic, Inc. 
Standard deviation throughout column. 
FIGURE 9. Pseudointima produced by WI-38 cells on a nylon 6,6 fabric only partly 
coated with carbon. The carbonized portion (below) is very compatible to, and 
almost completely covered with cells which are almost totally absent on the bare nylor. 
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FIGURE 10. Transmission electron micrograph of carbon-coated nylon fibers on 
either side of a WI-38 cell (WI).  Note that the carbon layer ( C )  has become frac- 
tured at the surface of the microfiber ( x  13,000). 
DISCUSSION 
The use of cell-lined microfiber scaffolds as blood interfaces depends upon 
(1) microfibers that are compatible with cells and durable in vivo: (2) the 
availability of nonthrombogenic, nonantigenic cells to line prostheses and the 
( 3 )  tissue culture technology capable of cultivating suitable cells and producing 
reliable pseudointimas. 
The present study demonstrates that tissue culture can provide a rapid and 
inexpensive procedure to screen materials and that there are wide differences 
in the biocompatibility of microfiber scaffolds to cultured cells in vitro. Carbon- 
coated fabrics are without question the best surface for cell growth encountered 
TABLE 3
COMPARISON OF CULTURE METHODS 
Cell Mean number of cells/mm' Minimum number of cells/mm' 
Type yielding 80-100% coverage yielding 80-100% coverage 
Static Perf usion Static Perfusion 
WI-38 (119)" 11980 (64) 9146 (119) 5100 (64) 2480 
Epidermis (50) 9108 (44) 5267 (50) 5600 (44) 1840 
* ( )=Number of cases. 
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to date. Other investigators have demonstrated this compatibility as well, includ- 
ing the fact that carbon offers some degree of thrombore~istance.~~* 38 Although 
it is possible to produce extremely thin carbon coatings on normally noncom- 
patible microfibers (i.e. nylon 6 , 6 ) ,  the brittleness of carbon would seem to 
preclude its use; the exception being those situations in which flexion was not 
required, such as in heart valves. 
The use of Parylene-C as a coating for microfibers appears to be much more 
satisfactory in terms of flexibility than carbon. Moreover, it is very compatible 
with cells and has the additional advantage of binding all of the fibers into a 
continuing web, thereby providing structural integrity of the scaffold and the 
backing. The long-term durability of this material in vivo, however, is unknown. 
We have some concern that these microfiber scaffolds might separate from the 
vessel wall at the point of adhesion (FIGURE 3 )  or between layers of the 
scaffold, under shearing forces encountered at systole. 
The best overall microfiber scaffold tested so far appears to be the polyester 
(polytetramethylene terephthalate) . This material gives excellent cell growth, 
requires no special treatment, and is firmly embedded into the vessel wall by 
the negative casting procedure. The only drawback of this type of material 
appears to be occasional roughness of the inner surface of the fabric. 
The physical nature of the microfiber scaffolds combined with an imperme- 
able estane wall used in these studies must be considered in terms of its potential 
use in vivo. The fiber and pore size appear to be optimal for cellular growth 
and penetration. The nonporous outer wall has direct applicability to blood 
pumps but is less useful in arterial or venous replacement because of its relative 
inflexibility and exclusion of transinterstices growth. Ideally, it may be useful 
to produce a vessel with a microfiber scaffold attached to a biodegradable outer 
wall. This wall would prevent hemorrhage after implantation but would subse- 
quently permit gradual replacement with connective tissue cells and ingrowth 
of blood vessels to the pseudointima. Ultimately, only the microfiber scaffold 
would remain as a supporting skeleton for the pseudointima and the connective 
tissue wall. 
Cell sources for nonthrombogenic, nonantigenic pseudointimal linings must 
take into account ease of acquisition, numbers of cells available, adaptability to 
the in vitro environment, rapidity of growth, and their in vivo behavior. From 
a technical point of view, the WI-38 cells used for establishing biocompatibility 
form excellent pseudointimas in vitro and are very durable in simulated vascular 
3* Yet, they would not be useful in vivo, since they are allogenic 
and, most likely, thrombogenic. While other investigators have used a variety 
of connective tissue *O, .lG they all required a fibrin coagulum. In one 
series of experiments Bernhard et aZ.'(; were able to use allogenic fetal fibroblasts 
to produce pseudointimas in calves without rejection. It is doubtful, however, 
that such allogenic cells would survive in other species or in adult cattle, for 
that matter. Rapidly growing fetal cells for pseudointimas would be useful only 
clinically if they were found to be nonthrombogenic and the immune response 
were lacking or could be suppressed without threat to the host. Since this is 
unlikely at the present time, potentially autologous cell lines seem to be the 
more reasonable approach. 
The ease of acquisition and abundance of epidermis makes this a useful cell 
type for pseudointimal production. Skin fragments were used by Adachi et U Z . ~ O  
to produce pseudointimas, but they found that fragments yielded rough surfaces 
and an irregular distribution of cells. Their attempts at producing pseudointimas 
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from subcultured skin were unsuccessful. In these studies, cultivated epidermal 
cells produce excellent pseudointimas of one to four layers of cells in vitro. 
While demonstrating structural differences depending upon their position, epi- 
dermal cells appear to modulate in their new environment and have never 
exhibited any keratinization. The question, however, remains as to whether 
these pseudointimas are nonthrombogenic. Preliminary studies indicate that the 
epidermal cells we have used are less thrombogenic than  fibroblast^.^' However, 
further studies are required and are currently under-way with canine epidermis. 
Although a natural endothelium would appear to be ideal because of its 
natural nonthrombogenicity and relative ease of acquisition from subcutaneous 
veins, culture of these cells is beset with technical problems. The first problem 
relates to the derivation of cells and the second to their slow growth in vitro, 
which appears to be only slightly faster than in vivo. Numerous investigators 
have cultivated fetal endothelial cells from human umbilical cord 48-54 and have 
used these cells extensively to study the properties of endothelium. These cells, 
however, are far different from adult endothelium in their adherence to under- 
lying connective tissue and their growth  characteristic^.^^ To be sure, adult 
endothelium grows very slowly in man, as is shown by healing rates of pros- 
theses4$ 56 Moreover, arterial and venous endothelium differ structurally from 
each other, as does the endothelium of either of these vessels in different parts 
of the same anima1.57 
Although cells derived from adult human endothelium do produce confluent 
pseudointimal linings for prostheses (FIGURE 7),  their ultimate use in clinical 
situations will depend upon the ability to enhance their proliferation. Perhaps 
adult endothelium requires a mitotic stimulant such as the “tumor angiogenesis 
factor,” 58 for, to our knowledge, no one has successfully cultivated adult human 
endothelial cells in quantity. Other investigators l B ,  20, 2* have used pieces of 
blood vessels to produce pseudointimas, but whether the linings produced were 
of endothelial, smooth muscle, or connective tissue origin is unknown. Mans- 
field et ~ 1 . ~ ~  has shown excellent pseudointimas produced in vitro with calf 
endothelial cells, and this work holds some promise. Whether it can be extrapo- 
lated to human tissue, however, remains a question, since calf endothelium is 
relatively easy to propagate in vitro and calves are known to coat naked pros- 
theses quite r a ~ i d l y . ~  Clearly, the calf is not the closest experimental model for 
The use of urothelial cells to produce pseudointimas is questionable at this 
time. That these cells will line prostheses in vitro is apparent. These cells 
proliferatae quite rapidly, but their usefulness is limited by the small amounts 
of tissue that may be obtained for culture. Consequently, they would be useful 
to line small prostheses, and then only if they are found to be nonthrombogenic. 
The advantages of perfusion over static cultures have been consistently 
demonstrated in this investigation. In all experiments we were able to produce 
comparable pseudointimas by perfusion culture with only 70% of the cells 
required to seed materials cultured under static conditions. These results cor- 
roborate those of Kruse et ~ 1 . ~ 9 - 6 1  in the production of multiple-layered popula- 
tions of cells. The improvement in results in perfusion culture relate not only 
to the steady state of the media nutrients, but also to the periodic exposure of 
the pseudointimas to air as the tubes rotate, thus providing oxygenation. 
The quality and completeness of pseudointimas produced also varies with 
the method of seeding the cells into the fabric. Various techniques have been 
employed, from simply pouring cells onto the surface of flat or concave de- 
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vices,35 to culturing tubes in a closed container with cells for a few hours,"G to 
the elaborate seeding devices of Ghidoni et al.,(I2 to the centrifugation and 
stabilization methods which we have employed."i. 'I" Even more complicated 
techniques will be necessary to seed and culture irregular shaped prostheses such 
as bifurcated tubes and specialized heart pumps. 
It must be emphasized that tissue culture technology applied to the produc- 
tion of cellular blood interfaces varies with the type of prosthesis and the cell 
line used. Different cell types will have specific requirements for their optimal 
derivation and cultivation in vitro. Equally important, the effects of culture 
media, nutrient turnover, temperature, osmolality, gaseous environment, water 
quality, and materials used in cell handling will all influence viability, growth, 
and pseudointima development:(? 
SUMMARY 
In an attempt to develop blood-compatible interfaces, cells were cultivated 
in vitro on microfiber scaffolds lining nonporous vascular prostheses and discs. 
The scaffolds were fabricated as nonwoven meshes of nylon and polyester (poly- 
tetramethylene terephthalate) ( Abcor, Inc.) or polypropylene (Union Carbide, 
Inc.). Microfibers ranged from 0.2 to 2 pm in diameter. The fibers were left 
bare, microwave discharge-treated, coated with carbon, Parylene-C, or combina- 
tions of these. WI-38 cells were used to test biocompatibility and potentially 
autologous human cell lines (epidermal, endothelial, and urinary tract epi- 
thelium) were used to produce pseudointimas. Tubes and discs were washed 
and degassed, seeded with cells by centrifugation, stabilized in a confined en- 
vironment, and cultivated by roller bottle perfusion or in Falcon tissue culture 
flasks. WI-38 cells produced 54-1 00% coverage, depending on the microfiber 
composition. Epidermal cells yielded excellent pseudointimas with the polyester 
microfibers as the best overall substrate and nylon microwave-treated fibers as 
the least effective. Adult human endothelium produced coverages of 28-94%, 
while urothelium provided the poorest pseudointimas. 
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